Dibenzo[b,d]furan-2,3-diamine, 97%, 250mg

AZTAK1 INHIBITOR, 98.0%, 5mg

(6R,7R)-Benzhydryl 7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride, 95%, 250mg

3-Fluorocyclobutanecarboxylic acid, 95.0%, 100mg

5-Hydroxy-1H-pyridin-2-one, 95.0%, 1g

4-(mesitylcarbonyl)benzoic acid, 95.0%, 1g

1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclobutanecarboxylic acid, 95%, 250mg

L-(-)-Indoline-2-carboxylic acid, 97.0%, 1g

Trimethylhexamethylene Diisocyanate (2,2,4- and 2,4,4- mixture)>97.0%(GC)25mL

2-(Dimethylamino)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 98%, 500mg

2-Ethoxyethyl 4-methylbenzene-1-sulfonate, 95+%, 1g

2-Amino-4-bromo-3,6-difluorobenzoic acid, 98%, 10g

Allyl heptanoate, 95.0%, 1kg